A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis
This study has been completed.
First Posted: January 7, 2011
Last Update Posted: September 18, 2012
Information provided by (Responsible Party):